Related Experiment Video
Updated: Jan 15, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Evaluation of an antibiotic stewardship program for promoting rational antibiotic use in an ICU in China
Yujin Guo1, Lu Kong1, Jingjing Liu1
1Department of Clinical Pharmacy & Pharmacology, Jining No.1 People's Hospital, Jining, 272011, China.
Background:
The irrational use of broad-spectrum antibiotics in intensive care units (ICUs) has led to increasing bacterial resistance in recent years. However, research on the effectiveness of antimicrobial stewardship programs (ASPs) in Chinese ICUs is limited. This study aimed to assess the impact of ASP implementation on antibiotic use and bacterial resistance in a Chinese ICU.
Methods:
This retrospective, interventional study employed an interrupted time series design and was conducted in an ICU beginning on June 1, 2019. The ASP included the formation of a multidisciplinary team, the development of facility-specific criteria, prescriber education, the implementation of preauthorization processes, and retrospective prescription audit and feedback (RPAF). Patient data were collected from June 1, 2018, to May 31, 2020. An interrupted time series analysis was used to evaluate the impact of the ASP.
Results:
A total of 862 patients were admitted during the pre-intervention period, and 946 patients were admitted during the post-intervention period. The interrupted time series analysis demonstrated a reduction in the monthly consumption of carbapenems (β3: -2.25 DDD/100 PD, p < 0.001) and linezolid (β3: -0.49 DDD/100 PD, p = 0.003) after the intervention. Additionally, a decrease in the incidence of bacteremia caused by multidrug-resistant (MDR) organisms overall (β3:-0.03 events/100 PD, p = 0.036) and MDR Gram-positive organisms (β3:-0.01 events/100 PD, p = 0.002) was observed post-intervention.
Conclusion:
Reduced antimicrobial consumption and decreased incidence of infections associated with MDR organisms were observed following the implementation of an ASP strategy that incorporated clinical pharmacists as core team members.
Clinical Trial Number:
Not applicable.
More Related Videos
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
03:22Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urine Studies II: Urine Culture and Sensitivity Test
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Antibiotic Selection
Antimicrobial Effectiveness
Acute Pyelonephritis II: Diagnostic Studies and Management